comparemela.com

Latest Breaking News On - Silvan tuerkcan - Page 6 : comparemela.com

Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought

The growth-focused money manager is making moves.

China
Cathie-wood
Silvan-tuerkcan
David-lebowitz
Teladoc-health
Ark-invest
Intellia-therapeutics
Full-self-driving

Crispr Therapeutics AG (CRSP) Receives a Buy from SVB Securities

In a report released on November 11, Mani Foroohar from SVB Securities maintained a Buy rating on Crispr Therapeutics AG (CRSP - Research Report)..

Switzerland
Matthew-porteus
Mani-foroohar
Daniel-anderson
Securitiess-silvan-tuerkcan
Rodger-novak
Emmanuelle-charpentier
Shaun-patrick-foy
Alnylam-pharma
Rocket-pharmaceuticals
Barclays
Crispr-therapeutics

MacroGenics (MGNX) Q3 2022 Earnings Call Transcript

MGNX earnings call for the period ending September 30, 2022.

China
Jessica-hui
Charles-zhu-guggenheim
Lukas-shumway
Silvan-tuerkcan
Charles-zhu
Jonathan-chang
Scott-koenig
James-karrels
David-dai
Finsight-corporation
Vice-president

Harvard University's Latest Portfolio: 5 Best Biotech Stock Picks

In this article, we will look at Harvard University s latest stock portfolio and list its 5 best biotech stock picks.

Silvan-tuerkcan
Robert-burns
Harvard-management-company
Relay-therapeutics-inc
Harvard-university
Harvard-university-latest-portfolio
Number-of-hedge-fund-holders
Nasdaq
Harvard-management
Latest-portfolio
Biotech-stock
Stake-value

Crispr Therapeutics Advances 366 Spots To 120th Most Popular With Retail Investors

Crispr Therapeutics AG (NASDAQ:CRSP) is a Swiss-American gene editing biotech company developing gene-based medicines

United-states
Russia
Switzerland
Ukraine
Henry-singleton
Silvan-tuerkcan
Benjamin-burnett
Chardan-research
Nasdaq
Crispr-therapeutics
Full-henry-singleton-series
Phuong-khanh-morrow

vimarsana © 2020. All Rights Reserved.